Unmet challenges in HIV therapy and potential of stampidine

Arzneimittel-Forschung/Drug Research

Volumn 56, Issue 2 A, 2006, Pages 117-120

  Uckun, Fatih M ^a,b  

^a PARKER HUGHES INSTITUTE   (United States)

^b Paradigm Pharmaceuticals   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; CAS 217178 62; DDE 113; HI 113; LAMIVUDINE; RNA DIRECTED DNA POLYMERASE INHIBITOR; STAMPIDINE; UNCLASSIFIED DRUG; ZIDOVUDINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANTIVIRAL ACTIVITY; EDITORIAL; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; VIRUS HEMORRHAGIC FEVER; VIRUS TRANSMISSION;

EID: 33645099474     PISSN: 00044172     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0031-1296799     Document Type: Editorial

References (22)

1. Executive Summary, Report on the Global AIDS Epidemic (2004)
2. Global Summary of the AIDS Epidemic (2005)
3. Moore, D., Montaner, J., Total lymphocyte counts and ART in resource-limited settings. Lancet 366, 1831 (2005)
4. Market Dynamics, HIV (2004)
5. Prevalence of antiretroviral drug resistance and resistance mutations in antiretroviral therapy naive HIV infected individuals from 44 US cities during 2003, 44th Interscience Conference of Antimicrobial Agents and Chemotherapy, Abstract H-173/300 (2004)
6. Uckun, F. M., Petkevich, A. S., Vassilev, A. O. et al., Stampidine prevents mortality in an experimental mouse model of viral hemorrhagic fever caused by lassa virus. BMC Infect. Dis. 4, 1 (2004)
7. Uckun, F. M., Qazi, S., Pendergrass, S. et al., In vivo toxicity, pharmacokinetics, and anti-human immunodeficiency virus activity of stavudine-5'-(p-bromophenyl methoxyalaninyl phosphate) (Stampidine) in mice. Antimicrob. Agents Chemother. 46, 3428 (2002)
8. Uckun, F. M., Chen, C. L., Samuel, P et al., In vivo antiretroviral activity of stampidine in chronically feline immunodeficiency virus-infected cats. Antimicrob. Agents Chemother. 47, 1233 (2003)
9. Holmes, W., Seeking Rational Policy Setting for PMTCT. Lancet 366, 1835 (2005)
10. Venkatachalam, T. K., Samuel, P., Li, G. et al., Lipase-mediated stereoselective hydrolysis of stampidine and other phosphoramidate derivatives of stavudine. Bioorg. Med. Chem. 12, 3371 (2004)
11. Venkatachalam, T. K., Samuel, P., Uckun, F. M., Enzymatic hydrolysis of stampidine and other stavudine phosphoramidates in the presence of mammalian proteases. Bioorg. Med. Chem. 13, 2651 (2005)
12. Venkatachalam, T. K., Samuel, P., Uckun, F. M., Stereochemical influence on lipase-mediated hydrolysis and biological activity of stampidine and other stavudine phosphoramidates. Bioorg. Med. Chem. 13, 1763 (2005)
13. Uckun, F. M., Chen, C. L., Lisowski, E. et al., Toxicity and pharmacokinetics of stampidine in mice and rats. Arzneim.-Forsch./Drug Res. 53, 357 (2003)
14. Uckun, F. M., Waurzyniak, B., Tibbles, H. E. et al., In vivo Pharmacokinetics and Toxicity Profile of the Anti-HIV Agent Stampidine in Dogs and Feline Immunodeficiency Virus-infected Cats. Arzneim.-Forsch./Drug Res. 56, 176 (2006)
15. Chen, C., Venkatachalam, T. K., Zhu, Z. et al., In vivo pharmacokinetics and metabolism of stampidine, a novel aryl phosphate derivative of d4T with potent anti-HIV activity. Drug Metab. Dispos. 29, 1035 (2001)
16. Chen, C. L., Yu, G., Venkatachalam, T. K. et al., Metabolism of stavudine-5'-[p-bromophenyl methoxyalaninyl phosphate], stampidine, in mice, dogs, and cats. Drug Metab. Dispos. 30, 1523 (2002)
17. United States Patent No. 6030957. Aryl phosphate derivatives of d4T having anti-HIV activity. Uckun, E, Vig, R.
18. United States Patent No. 6350736. Aryl phosphate derivatives of d4T having anti-HIV activity, Uckun, F. M., Vig, R.
19. United States Patent No. 6503890. Aryl phosphate derivatives of d4T having anti-HIV activity. Uckun, F. M.
20. United States Patent No. 6528495. Aryl phosphate derivatives of d4T having anti-HIV activity. Uckun, F. M., Vig, R.
21. Uckun, F. M., Pendergrass, S., Qazi, S. et al., In vitro activity of stampidine against primary clinical human immunodeficiency virus isolates. Arzneim.-Forsch./Drug Res. 54, 69 (2004)
22. Uckun, F. M., Pendergrass, S., Venkatachalam, T. K. et al., Stampidine is a potent inhibitor of Zidovudine- and nucleoside analog reverse transcriptase inhibitor-resistant primary clinical human immunodeficiency virus type 1 isolates with thymidine analog mutations. Antimicrob. Agents Chemother. 46, 3613 (2002)